[Influences of agents which affect ionic conductance on the tachycardiac effect of catecholamines: antitachycardiac effect].
D001498:3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester / Q000494:pharmacology; D000818:Animals; D001464:Barium / Q000494:pharmacology; D017609:Barium Compounds; D002586:Cesium / Q000494:pharmacology; D002712:Chlorides; D004305:Dose-Response Relationship, Drug; D004553:Electric Conductivity / Q000187:drug effects*; D005260:Female; D006168:Guinea Pigs; D006339:Heart Rate / Q000187:drug effects*; D066298:In Vitro Techniques; D007477:Ions; D007545:Isoproterenol / Q000037:antagonists & inhibitors*; D008297:Male; D019789:Tetraethylammonium; D013757:Tetraethylammonium Compounds / Q000494:pharmacology
D017609:Barium Compounds; D002712:Chlorides; D007477:Ions; D013757:Tetraethylammonium Compounds; C024986:barium chloride; D002586:Cesium; D001464:Barium; D019789:Tetraethylammonium; D001498:3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; C028019:cesium chloride; D007545:Isoproterenol